223 related articles for article (PubMed ID: 35042625)
1. Outcome After Thrombolysis in Patients With Intermediate High-Risk Pulmonary Embolism: A Propensity Score Analysis.
Zimmermann L; Laufs U; Petros S; Lenk K
J Emerg Med; 2022 Mar; 62(3):378-389. PubMed ID: 35042625
[TBL] [Abstract][Full Text] [Related]
2. Clinical update on thrombolytic use in pulmonary embolism: A focus on intermediate-risk patients.
Eberle H; Lyn R; Knight T; Hodge E; Daley M
Am J Health Syst Pharm; 2018 Sep; 75(17):1275-1285. PubMed ID: 29895520
[TBL] [Abstract][Full Text] [Related]
3. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism.
Riera-Mestre A; Jiménez D; Muriel A; Lobo JL; Moores L; Yusen RD; Casado I; Nauffal D; Oribe M; Monreal M;
J Thromb Haemost; 2012 May; 10(5):751-9. PubMed ID: 22417297
[TBL] [Abstract][Full Text] [Related]
4. Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis.
Planer D; Yanko S; Matok I; Paltiel O; Zmiro R; Rotshild V; Amir O; Elbaz-Greener G; Raccah BH
CMAJ; 2023 Jun; 195(24):E833-E843. PubMed ID: 37336568
[TBL] [Abstract][Full Text] [Related]
5. Utilization of catheter-directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter-directed thrombolysis.
Patel N; Patel NJ; Agnihotri K; Panaich SS; Thakkar B; Patel A; Savani C; Patel N; Arora S; Deshmukh A; Bhatt P; Alfonso C; Cohen M; Tafur A; Elder M; Mohamed T; Attaran R; Schreiber T; Grines C; Badheka AO
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1219-27. PubMed ID: 26308961
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Effectiveness between Anticoagulation and Thrombolysis Therapy for Pulmonary Embolism in Patients Complicated with Shock: A Nationwide Population-Based Study.
Lee JK; Chen WH; Lin YS; Chang CH; Chen TH
Thromb Haemost; 2020 Aug; 120(8):1208-1216. PubMed ID: 32679597
[TBL] [Abstract][Full Text] [Related]
7. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.
Chatterjee S; Chakraborty A; Weinberg I; Kadakia M; Wilensky RL; Sardar P; Kumbhani DJ; Mukherjee D; Jaff MR; Giri J
JAMA; 2014 Jun; 311(23):2414-21. PubMed ID: 24938564
[TBL] [Abstract][Full Text] [Related]
8. Systemic Thrombolysis for Pulmonary Embolism: Who and How.
Tapson VF; Friedman O
Tech Vasc Interv Radiol; 2017 Sep; 20(3):162-174. PubMed ID: 29029710
[TBL] [Abstract][Full Text] [Related]
9. Systemic thrombolysis with newer thrombolytics vs anticoagulation in acute intermediate risk pulmonary embolism: a systematic review and meta-analysis.
Mathew D; Seelam S; Bumrah K; Sherif A; Shrestha U
BMC Cardiovasc Disord; 2023 Sep; 23(1):482. PubMed ID: 37770910
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism.
Zhang RS; Maqsood MH; Sharp ASP; Postelnicu R; Sethi SS; Greco A; Alviar C; Bangalore S
JACC Cardiovasc Interv; 2023 Nov; 16(21):2644-2651. PubMed ID: 37855802
[TBL] [Abstract][Full Text] [Related]
11. Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial.
Sanchez O; Charles-Nelson A; Ageno W; Barco S; Binder H; Chatellier G; Duerschmied D; Empen K; Ferreira M; Girard P; Huisman MV; Jiménez D; Katsahian S; Kozak M; Lankeit M; Meneveau N; Pruszczyk P; Petris A; Righini M; Rosenkranz S; Schellong S; Stefanovic B; Verhamme P; de Wit K; Vicaut E; Zirlik A; Konstantinides SV; Meyer G;
Thromb Haemost; 2022 May; 122(5):857-866. PubMed ID: 34560806
[TBL] [Abstract][Full Text] [Related]
12. Treatment of high- and intermediate-high-risk pulmonary embolism by the Pulmonary Embolism Response Team: Focus on catheter-directed therapies.
Pietrasik A; Kurzyna P; Szwed P; Jasińska-Gniadzik K; Gąsecka A; Darocha S; Zieliński D; Szarpak Ł; Kochman J; Grabowski M; Opolski G; Torbicki A; Kurzyna M
Cardiol J; 2024; 31(2):215-225. PubMed ID: 37519055
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Efficacy and Safety between Thrombolysis Plus Anticoagulation vs. Anticoagulation Alone for the Treatment of Acute Submassive Pulmonary Embolism: A Systematic Review and Meta-analysis.
Pan Q; Gao H; Wang Y; Chen Q
Curr Vasc Pharmacol; 2022; 20(6):491-500. PubMed ID: 35959626
[TBL] [Abstract][Full Text] [Related]
14. Transforming and simplifying the treatment of pulmonary embolism: "safe dose" thrombolysis plus new oral anticoagulants.
Sharifi M; Vajo Z; Freeman W; Bay C; Sharifi M; Schwartz F
Lung; 2015 Jun; 193(3):369-74. PubMed ID: 25749665
[TBL] [Abstract][Full Text] [Related]
15. Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli.
Matusov Y; Yaqoob M; Karumanchi A; Lipshutz HG; Dohad S; Steinberger J; Lopez A; Singh S; Tapson VF; Friedman O
Thromb Res; 2023 May; 225():57-62. PubMed ID: 37003150
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.
Avgerinos ED; Saadeddin Z; Abou Ali AN; Fish L; Toma C; Chaer M; Rivera-Lebron BN; Chaer RA
J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):530-540. PubMed ID: 29909859
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claims.
Geller BJ; Adusumalli S; Pugliese SC; Khatana SAM; Nathan A; Weinberg I; Jaff MR; Kobayashi T; Mazurek JA; Khandhar S; Yang L; Groeneveld PW; Giri JS
Vasc Med; 2020 Aug; 25(4):334-340. PubMed ID: 32338580
[TBL] [Abstract][Full Text] [Related]
18. Controversies in the Management of Life-Threatening Pulmonary Embolism.
Marshall PS; Tapson V; Jiménez D
Semin Respir Crit Care Med; 2015 Dec; 36(6):835-41. PubMed ID: 26595043
[TBL] [Abstract][Full Text] [Related]
19. Systemic Thrombolysis, Catheter-Directed Thrombolysis, and Anticoagulation for Intermediate-risk Pulmonary Embolism: A Simulation Modeling Analysis.
Kabrhel C; Ali A; Choi JG; Hur C
Acad Emerg Med; 2017 Oct; 24(10):1235-1243. PubMed ID: 28650086
[TBL] [Abstract][Full Text] [Related]
20. Short- and Long-Term Outcomes of Catheter-Directed Thrombolysis versus Pulmonary Artery Embolectomy in Pulmonary Embolism: A National Population-Based Study.
Lin DS; Lin YS; Lee JK; Chen WJ
J Endovasc Ther; 2022 Jun; 29(3):409-419. PubMed ID: 34706585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
